Published in Public Health Rep on March 01, 2005
Evaluation of Behavioral Intervention for HIV Positive Prisoners in NC and TX (imPACT) | NCT01629316
Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International Association of Physicians in AIDS Care panel. Ann Intern Med (2012) 7.04
Accessing antiretroviral therapy following release from prison. JAMA (2009) 5.45
Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. Lancet (2010) 3.90
Prisoner survival inside and outside of the institution: implications for health-care planning. Am J Epidemiol (2011) 2.61
Dose-response effect of incarceration events on nonadherence to HIV antiretroviral therapy among injection drug users. J Infect Dis (2011) 2.55
HIV/AIDS and other infectious diseases among correctional inmates: transmission, burden, and an appropriate response. Am J Public Health (2006) 2.20
Optimization of human immunodeficiency virus treatment during incarceration: viral suppression at the prison gate. JAMA Intern Med (2014) 1.86
Incarceration and high-risk sex partnerships among men in the United States. J Urban Health (2009) 1.83
Improved HIV and substance abuse treatment outcomes for released HIV-infected prisoners: the impact of buprenorphine treatment. J Urban Health (2010) 1.66
Opportunities to diagnose, treat, and prevent HIV in the criminal justice system. J Acquir Immune Defic Syndr (2010) 1.62
Enrollment in outpatient care among newly released prison inmates with HIV infection. Public Health Rep (2010) 1.54
Intensive case management before and after prison release is no more effective than comprehensive pre-release discharge planning in linking HIV-infected prisoners to care: a randomized trial. AIDS Behav (2011) 1.52
HIV, alcohol dependence, and the criminal justice system: a review and call for evidence-based treatment for released prisoners. Am J Drug Alcohol Abuse (2010) 1.48
The role of prevention in promoting continuity of health care in prisoner reentry initiatives. Am J Public Health (2013) 1.41
A longitudinal study of incarceration and HIV risk among methadone maintained men and their primary female partners. AIDS Behav (2011) 1.40
Antiretroviral treatment regimen outcomes among HIV-infected prisoners. HIV Clin Trials (2007) 1.39
Correlates of retention in HIV care after release from jail: results from a multi-site study. AIDS Behav (2013) 1.39
Retention on buprenorphine is associated with high levels of maximal viral suppression among HIV-infected opioid dependent released prisoners. PLoS One (2012) 1.37
Understanding the revolving door: individual and structural-level predictors of recidivism among individuals with HIV leaving jail. AIDS Behav (2013) 1.35
Linking HIV-positive jail inmates to treatment, care, and social services after release: results from a qualitative assessment of the COMPASS Program. J Urban Health (2010) 1.35
Prevalence of chronic medical conditions among inmates in the Texas prison system. J Urban Health (2010) 1.29
Incarceration predicts virologic failure for HIV-infected injection drug users receiving antiretroviral therapy. Clin Infect Dis (2011) 1.29
Highly active antiretroviral therapy use and HIV transmission risk behaviors among individuals who are HIV infected and were recently released from jail. Am J Public Health (2008) 1.27
HIV-related research in correctional populations: now is the time. Curr HIV/AIDS Rep (2011) 1.25
Optimizing care for HIV-infected people who use drugs: evidence-based approaches to overcoming healthcare disparities. Clin Infect Dis (2013) 1.24
HIV transmission in a state prison system, 1988-2005. PLoS One (2009) 1.24
From corrections to communities as an HIV priority. J Urban Health (2006) 1.22
A high risk of hospitalization following release from correctional facilities in Medicare beneficiaries: a retrospective matched cohort study, 2002 to 2010. JAMA Intern Med (2013) 1.19
Condom use and duration of concurrent partnerships among men in the United States. Sex Transm Dis (2009) 1.18
Emergency department use by released prisoners with HIV: an observational longitudinal study. PLoS One (2012) 1.11
Predictors of reincarceration and disease progression among released HIV-infected inmates. AIDS Patient Care STDS (2010) 1.11
The HIV Care Cascade Before, During, and After Incarceration: A Systematic Review and Data Synthesis. Am J Public Health (2015) 1.11
Post-release substance abuse outcomes among HIV-infected jail detainees: results from a multisite study. AIDS Behav (2013) 1.09
Attitudes toward opioid substitution therapy and pre-incarceration HIV transmission behaviors among HIV-infected prisoners in Malaysia: implications for secondary prevention. Drug Alcohol Depend (2011) 1.09
HIV among persons incarcerated in the USA: a review of evolving concepts in testing, treatment, and linkage to community care. Curr Opin Infect Dis (2013) 1.07
HIV Treatment in the Criminal Justice System: Critical Knowledge and Intervention Gaps. AIDS Res Treat (2011) 1.06
Multilevel challenges to engagement in HIV care after prison release: a theory-informed qualitative study comparing prisoners' perspectives before and after community reentry. BMC Public Health (2014) 1.01
HIV testing and treatment with correctional populations: people, not prisoners. J Health Care Poor Underserved (2010) 1.00
Rationale, study design and sample characteristics of a randomized controlled trial of directly administered antiretroviral therapy for HIV-infected prisoners transitioning to the community - a potential conduit to improved HIV treatment outcomes. Contemp Clin Trials (2011) 0.99
The impact of antiretroviral therapy in a cohort of HIV infected patients going in and out of the San Francisco county jail. PLoS One (2009) 0.94
Gender-specific correlates of incarceration among marginally housed individuals in San Francisco. Am J Public Health (2009) 0.93
Tracking linkage to HIV care for former prisoners: a public health priority. Virulence (2012) 0.93
Barriers and facilitators to engagement of vulnerable populations in HIV primary care in New York City. J Acquir Immune Defic Syndr (2015) 0.93
HIV-infected prison inmates: depression and implications for release back to communities. AIDS Behav (2008) 0.92
HIV in people reincarcerated in Connecticut prisons and jails: an observational cohort study. Lancet HIV (2014) 0.92
The Institutional Effects of Incarceration: Spillovers From Criminal Justice to Health Care. Milbank Q (2015) 0.91
Information and Communication Technology to Link Criminal Justice Reentrants to HIV Care in the Community. AIDS Res Treat (2013) 0.89
Partner violence and health among HIV-infected jail detainees. Int J Prison Health (2013) 0.88
The role of jails in engaging PLWHA in care: from jail to community. AIDS Behav (2013) 0.87
Antiretroviral outcomes in South African prisoners: a retrospective cohort analysis. PLoS One (2012) 0.86
HIV treatment in US prisons. HIV Ther (2010) 0.85
Within-prison drug injection among HIV-infected Ukrainian prisoners: prevalence and correlates of an extremely high-risk behaviour. Int J Drug Policy (2014) 0.85
Improving healthcare for incarcerated women. J Womens Health (Larchmt) (2010) 0.84
Frequent emergency department use among released prisoners with human immunodeficiency virus: characterization including a novel multimorbidity index. Acad Emerg Med (2013) 0.84
Directly observed versus self-administered antiretroviral therapies: preference of HIV-positive jailed inmates in San Francisco. J Urban Health (2012) 0.82
Transitions to Care in the Community for Prison Releasees with HIV: a Qualitative Study of Facilitators and Challenges in Two States. J Urban Health (2015) 0.82
Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for HIV-infected, opioid dependent prisoners and jail detainees who are transitioning to the community. Contemp Clin Trials (2014) 0.81
An ecosystem-based intervention to reduce HIV transmission risk and increase medication adherence among inmates being released to the community. J Correct Health Care (2013) 0.81
HIV treatment and care among Italian inmates: a one-month point survey. BMC Infect Dis (2015) 0.80
Harm reduction and equity of access to care for French prisoners: a review. Harm Reduct J (2008) 0.80
"You're in a world of chaos": experiences accessing HIV care and adhering to medications after incarceration. J Assoc Nurses AIDS Care (2015) 0.79
Sex-Related Disparities in Criminal Justice and HIV Treatment Outcomes: A Retrospective Cohort Study of HIV-Infected Inmates. Am J Public Health (2015) 0.79
Provider perspectives regarding the health care needs of a key population: HIV-infected prisoners after incarceration. J Assoc Nurses AIDS Care (2015) 0.78
Health status, sexual and drug risk, and psychosocial factors relevant to postrelease planning for HIV+ prisoners. J Correct Health Care (2013) 0.77
Incarceration and health outcomes in HIV-infected patients: the impact of substance use, primary care engagement, and antiretroviral adherence. Am J Addict (2015) 0.77
Combined antiretroviral and anti-tuberculosis drug resistance following incarceration. South Afr J HIV Med (2013) 0.77
Emergency department use among HIV-infected released jail detainees. J Urban Health (2015) 0.75
Individuals motivated to participate in adherence, care and treatment (imPACT): development of a multi-component intervention to help HIV-infected recently incarcerated individuals link and adhere to HIV care. BMC Public Health (2016) 0.75
Women in community corrections in New York City: HIV infection and risks. Int J STD AIDS (2016) 0.75
Gender Differences in HIV Care among Criminal Justice-Involved Persons: Baseline Data from the CARE+ Corrections Study. PLoS One (2017) 0.75
Black Americans and Incarceration: A Neglected Public Health Opportunity for HIV Risk Reduction. J Health Care Poor Underserved (2016) 0.75
Transitional care for formerly incarcerated persons with HIV: protocol for a realist review. Syst Rev (2017) 0.75
Justice-involved health information: policy and practice advances in Connecticut. Perspect Health Inf Manag (2014) 0.75
Exploring Relationships Between Delinquent Peer Groups, Participation in Delinquency, Substance Abuse, and Injecting Drug Use Among the Incarcerated: Findings From a National Sample of State and Federal Inmates in the United States. J Drug Issues (2017) 0.75
Design and implementation of a factorial randomized controlled trial of methadone maintenance therapy and an evidence-based behavioral intervention for incarcerated people living with HIV and opioid dependence in Malaysia. Contemp Clin Trials (2017) 0.75
Understanding interactions of formerly incarcerated HIV-positive men and transgender women with substance use treatment, medical, and criminal justice systems. Int J Drug Policy (2017) 0.75
Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med (2000) 23.10
A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med (2001) 9.98
The burden of infectious disease among inmates of and releasees from US correctional facilities, 1997. Am J Public Health (2002) 8.17
Human immunodeficiency virus in correctional facilities: a review. Clin Infect Dis (2002) 3.27
Patient decision support intervention: increased consistency with decision analytic models. Med Care (1999) 1.64
Adherence to complex combination antiretroviral therapies by HIV-positive drug abusers. Psychiatr Serv (1998) 1.48
Human susceptibility and resistance to Norwalk virus infection. Nat Med (2003) 7.07
A prospective study of predictors of adherence to combination antiretroviral medication. J Gen Intern Med (2002) 4.49
Men who have sex with men and women: a unique risk group for HIV transmission on North Carolina College campuses. Sex Transm Dis (2006) 3.34
Sex with older partners is associated with primary HIV infection among men who have sex with men in North Carolina. J Acquir Immune Defic Syndr (2010) 2.89
Interventions to improve adherence to self-administered medications for chronic diseases in the United States: a systematic review. Ann Intern Med (2012) 2.81
Repeated measures longitudinal analyses of HIV virologic response as a function of percent adherence, dose timing, genotypic sensitivity, and other factors. J Acquir Immune Defic Syndr (2006) 2.65
Sexual behaviours of HIV-seropositive men and women following release from prison. Int J STD AIDS (2006) 2.58
Comparison of polychlorinated biphenyl levels across studies of human neurodevelopment. Environ Health Perspect (2003) 2.41
All-cause and cause-specific mortality among men released from state prison, 1980-2005. Am J Public Health (2008) 2.19
Knowledge of antiretroviral regimen dosing and adherence: a longitudinal study. Clin Infect Dis (2003) 2.05
The unexpected movement of the HIV epidemic in the Southeastern United States: transmission among college students. J Acquir Immune Defic Syndr (2005) 1.93
A 2-arm, randomized, controlled trial of a motivational interviewing-based intervention to improve adherence to antiretroviral therapy (ART) among patients failing or initiating ART. J Acquir Immune Defic Syndr (2006) 1.85
How well do clinicians estimate patients' adherence to combination antiretroviral therapy? J Gen Intern Med (2002) 1.84
Incarceration and risky sexual partnerships in a southern US city. J Urban Health (2007) 1.83
Randomized study of the safety and efficacy of fish oil (omega-3 fatty acid) supplementation with dietary and exercise counseling for the treatment of antiretroviral therapy-associated hypertriglyceridemia. Clin Infect Dis (2005) 1.76
Putting prevention in their pockets: developing mobile phone-based HIV interventions for black men who have sex with men. AIDS Patient Care STDS (2013) 1.74
Preferences for medical collaboration: patient-physician congruence and patient outcomes. Patient Educ Couns (2005) 1.71
HIV and incarceration: dual epidemics. AIDS Read (2006) 1.67
Timing and duration of incarceration and high-risk sexual partnerships among African Americans in North Carolina. Ann Epidemiol (2008) 1.60
HIV acquisition among women from selected areas of the United States: a cohort study. Ann Intern Med (2013) 1.59
"It's all the time in my mind": facilitators of adherence to antiretroviral therapy in a Tanzanian setting. Soc Sci Med (2009) 1.55
How new subscribers use cancer-related online mailing lists. J Med Internet Res (2005) 1.54
Intensive case management before and after prison release is no more effective than comprehensive pre-release discharge planning in linking HIV-infected prisoners to care: a randomized trial. AIDS Behav (2011) 1.52
Initial cleavage of the human immunodeficiency virus type 1 GagPol precursor by its activated protease occurs by an intramolecular mechanism. J Virol (2004) 1.52
Discrimination, distrust, and racial/ethnic disparities in antiretroviral therapy adherence among a national sample of HIV-infected patients. J Acquir Immune Defic Syndr (2008) 1.51
Processing sites in the human immunodeficiency virus type 1 (HIV-1) Gag-Pro-Pol precursor are cleaved by the viral protease at different rates. Retrovirology (2005) 1.48
Efficacy of uterine artery embolisation for treatment of symptomatic fibroids and adenomyosis - an interim report on an Australian experience. Aust N Z J Obstet Gynaecol (2012) 1.47
Testing for HIV, sexually transmitted infections, and viral hepatitis in jails: still a missed opportunity for public health and HIV prevention. J Acquir Immune Defic Syndr (2010) 1.47
A practical method to calibrate self-reported adherence to antiretroviral therapy. J Acquir Immune Defic Syndr (2006) 1.42
Associations among race/ethnicity, ApoC-III genotypes, and lipids in HIV-1-infected individuals on antiretroviral therapy. PLoS Med (2006) 1.40
Serostatus disclosure to sexual partners among people living with HIV: examining the roles of partner characteristics and stigma. AIDS Care (2012) 1.38
Disease prevalence and use of health care among a national sample of black and white male state prisoners. J Health Care Poor Underserved (2012) 1.34
Triple-class antiretroviral drug resistance: risk and predictors among HIV-1-infected patients. AIDS (2007) 1.33
Adherence to directly observed antiretroviral therapy among human immunodeficiency virus-infected prison inmates. Clin Infect Dis (2003) 1.33
Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV. AIDS (2007) 1.29
Screening and assessment of coronary heart disease in HIV-infected patients. Circulation (2008) 1.29
Ordered processing of the human immunodeficiency virus type 1 GagPol precursor is influenced by the context of the embedded viral protease. J Virol (2005) 1.28
Challenges of a hidden epidemic: HIV prevention among women in the United States. J Acquir Immune Defic Syndr (2010) 1.27
Failure to return for HIV posttest counseling in an STD clinic population. AIDS Educ Prev (2003) 1.26
HIV-related research in correctional populations: now is the time. Curr HIV/AIDS Rep (2011) 1.25
The dimer interfaces of protease and extra-protease domains influence the activation of protease and the specificity of GagPol cleavage. J Virol (2003) 1.25
Researching Aboriginal health: experience from a study of urban young people's health and well-being. Soc Sci Med (2002) 1.24
HIV-1 drug resistance evolution among patients on potent combination antiretroviral therapy with detectable viremia. J Acquir Immune Defic Syndr (2005) 1.23
Low-level prenatal and postnatal blood lead exposure and adrenocortical responses to acute stress in children. Environ Health Perspect (2008) 1.23
Brief motivational interviewing to improve adherence to antiretroviral therapy: development and qualitative pilot assessment of an intervention. AIDS Patient Care STDS (2004) 1.21
Dissolution of primary intimate relationships during incarceration and associations with post-release STI/HIV risk behavior in a Southeastern city. Sex Transm Dis (2011) 1.20
Cytomegalovirus viremia, mortality, and end-organ disease among patients with AIDS receiving potent antiretroviral therapies. J Acquir Immune Defic Syndr (2005) 1.19
Risk factors for Kaposi's sarcoma among HHV-8 seropositive homosexual men with AIDS. Int J Cancer (2005) 1.14
Dissolution of primary intimate relationships during incarceration and implications for post-release HIV transmission. J Urban Health (2011) 1.14
MACH14: a multi-site collaboration on ART adherence among 14 institutions. AIDS Behav (2013) 1.14
All-cause and cause-specific mortality among black and white North Carolina state prisoners, 1995-2005. Ann Epidemiol (2011) 1.13
Psychosocial characteristics and sexual behaviors of people in care for HIV infection: an examination of men who have sex with men, heterosexual men and women. AIDS Behav (2009) 1.12
A marginalized zero-inflated Poisson regression model with overall exposure effects. Stat Med (2014) 1.11
Modeling the impact of Trichomonas vaginalis infection on HIV transmission in HIV-infected individuals in medical care. Sex Transm Dis (2012) 1.10
Characteristics and behaviors associated with HIV infection among inmates in the North Carolina prison system. Am J Public Health (2009) 1.09
Translating concern into action: HIV care providers' views on counseling patients about HIV prevention in the clinical setting. AIDS Behav (2007) 1.08
A close halo of large transparent grains around extreme red giant stars. Nature (2012) 1.07
Evaluating nurses' implementation of an infant-feeding counseling protocol for HIV-infected mothers: The Ban Study in Lilongwe, Malawi. AIDS Educ Prev (2009) 1.07
Systematic review: effect of alcohol intake on adherence to outpatient medication regimens for chronic diseases. J Stud Alcohol Drugs (2012) 1.06
Factors associated with self-reported adherence to antiretroviral therapy in a Tanzanian setting. AIDS Care (2010) 1.05
An evaluation of HIV testing among inmates in the North Carolina prison system. Am J Public Health (2009) 1.05
A targeted decision aid for the elderly to decide whether to undergo colorectal cancer screening: development and results of an uncontrolled trial. BMC Med Inform Decis Mak (2010) 1.02
No evidence of an association between transient HIV viremia ("Blips") and lower adherence to the antiretroviral medication regimen. J Infect Dis (2004) 1.01
Genital tract, cord blood, and amniotic fluid exposures of seven antiretroviral drugs during and after pregnancy in human immunodeficiency virus type 1-infected women. Antimicrob Agents Chemother (2009) 1.01
Motivational interviewing to support antiretroviral therapy adherence: the role of quality counseling. Patient Educ Couns (2005) 1.01
Multilevel challenges to engagement in HIV care after prison release: a theory-informed qualitative study comparing prisoners' perspectives before and after community reentry. BMC Public Health (2014) 1.01
Retention strategies and factors associated with missed visits among low income women at increased risk of HIV acquisition in the US (HPTN 064). AIDS Patient Care STDS (2014) 0.99
Perceived everyday racism, residential segregation, and HIV testing among patients at a sexually transmitted disease clinic. Am J Public Health (2009) 0.99
Role of the HIV/AIDS case manager: analysis of a case management adherence training and coordination program in North Carolina. AIDS Patient Care STDS (2006) 0.98
Identifying people with acute HIV infection: demographic features, risk factors, and use of health care among individuals with AHI in North Carolina. AIDS Behav (2009) 0.98
Repeated measures analyses of dose timing of antiretroviral medication and its relationship to HIV virologic outcomes. Stat Med (2007) 0.96
Resident physicians' life expectancy estimates and colon cancer screening recommendations in elderly patients. Med Decis Making (2008) 0.96
HIV and stigma: analysis and research program. Curr HIV/AIDS Rep (2005) 0.96
Neurodevelopmental trajectory of HIV-infected children accessing care in Kinshasa, Democratic Republic of Congo. J Acquir Immune Defic Syndr (2009) 0.95
The validity of self-reported medication adherence as an outcome in clinical trials of adherence-promotion interventions: Findings from the MACH14 study. AIDS Behav (2014) 0.95
Prenatal and early childhood blood lead levels and cardiovascular functioning in 9(1/2) year old children. Neurotoxicol Teratol (2005) 0.95
Racism and health among urban Aboriginal young people. BMC Public Health (2011) 0.93
Antiviral activity, pharmacokinetics, and safety of BMS-488043, a novel oral small-molecule HIV-1 attachment inhibitor, in HIV-1-infected subjects. Antimicrob Agents Chemother (2010) 0.93
Promoting prostate-specific antigen informed decision-making. Evaluating two community-level interventions. Am J Prev Med (2008) 0.93
Availability of and access to medical services among HIV-infected inmates incarcerated in North Carolina county jails. J Health Care Poor Underserved (2004) 0.93
Tracking linkage to HIV care for former prisoners: a public health priority. Virulence (2012) 0.93
Risk factors for human herpesvirus 8 seropositivity in the AIDS Cancer Cohort Study. J Clin Virol (2006) 0.93
Methodologic challenges of e-health research. Eval Program Plann (2006) 0.92